Universität Regensburg

The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD (2025) Akahoshi Y, Portelli J, Katsivelos N, Louloudis IE, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, et al. Journal article Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial (2025) Kolberg HC, Schumacher J, Erber R, Braun M, Fasching P, Grischke EM, Schem C, et al. Journal article Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma (2025) Kührer N, Huebner-Resch I, Mayr R, Agaimy A, Kronbichler A, Hartmann A, Schmidinger M, Pichler R Journal article, Review article High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands (2025) Ertl FJ, Friedel A, Schmid EJ, Höring C, Archipowa N, Koch P, Maschauer S, et al. Journal article Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC (2025) Akahoshi Y, Inamoto Y, Spyrou N, Nakasone H, Diniz MA, Asada N, Ayuk F, et al. Journal article Inherently interpretable machine learning: A contrasting paradigm to post-hoc explainable AI (Forthcoming) (2025) Zschech P, Weinzierl S, Kraus M Journal article, Original article Enhanced diagnostic potential of CSPG4 in melanoma and nevi: a comparative study with PRAME, CDC7 and Ki67 (2025) Koch E, Seidel C, Erber R, Erdmann M, Heppt M, Schliep S, Berking C, et al. Journal article High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteins (2025) Skowronek D, Pilz RA, Saenko VV, Mellinger L, Singer D, Ribback S, Weise A, et al. Journal article Metabolomic profiling of renal cyst fluid in advanced ADPKD: insights from dialysis and transplantation cohorts (2025) Heckscher S, Ihlo NA, Schueler J, Kellermeier F, Werner JM, Nübel B, Gross V, et al. Journal article Molecular pathology and antibody–drug conjugates: Light at the end of the tunnel for recurrent ovarian cancer Molekularpathologie und Antikörper-Wirkstoff-Konjugate: Licht am Ende des Tunnels beim rezidivierten Ovarialkarzinom (2025) Lüftner D, Erber R, Ataseven B, Lordick F Journal article